IL1B and breast carcinoma: In the current study, we convert to evaluate the differential expression and clinicopathological features of NLRP3 inflammasome pathway-related proteins, including NLRP3, caspase-1, ASC, IL-1β, and IL-18, in the tumor parenchymal and immune-stromal cells of breast cancer.